Effect of radiation dose in radiosurgery and radiotherapy on hearing loss in vestibular schwannoma


  • Minimal radiation dose is an accurate predictor of delayed hearing loss after stereotactic radiosurgery (SRS) or fractionated stereotactic radiotherapy (fSRT) for vestibular schwannoma (VS).

Why this matters

  • While SRS and fSRT are safe and effective VS treatments, hearing loss remains a significant side effect.

  • Understanding the relationship between radiation dose and progression of hearing loss may improve hearing outcomes for patients undergoing SRS and fSRT treatment for VS.